Immune phenotyping of leukocytes in the peripheral blood of MS patients has uncovered a higher frequency of CD4+ T cells with high avidity for myelin peptides in comparison with healthy subjects and that these cells are significantly skewed toward a Th1-polarized profile [21, 22]. The gene discussed is CD4; the disease is myeloid sarcoma.